3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Vitamin D Deficiency
20
Prostatic Neoplasms
17
Polycystic Ovary Syndrome
9
Neoplasms
9
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Osteoporosis
5
Myelodysplastic Syndromes
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
Vitamin D
1
Valsartan
1
Pyridostigmine Bromide
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Music Therapy
1
Melphalan
1
Ipilimumab
1
Infliximab
1
Immunoglobulins, Intravenous
1
Hydroxychloroquine
1
Fish Oils
1
Fatty Acids, Omega-3
1
Etoposide
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Autoimmune Diseases
×
Cholecalciferol
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts